日期: 2026-03-17
代码: 1875.HK
事件: 股东增减持（股东增减持）
药明生物于2026-03-17场外增持4.637亿股，每股均价4港元，最新持股数目4.637亿股，最新持股比例60% @#$ WuXi XDC Cayman Inc., a direct subsidiary of WuXi Biologics (Cayman) Inc., has received valid acceptances to acquire 463,672,734 Shares under the Share Offer for HK$4.0 per Share, which became unconditional in all respects on 17 March 2026. For more information, and for the definitions of capitalised terms used in this paragraph, please refer to the announcement jointly issued by WuXi XDC Cayman Inc. and BioDlink International Company Limited dated 17 March 2026.